Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Br J Pharmacol
2001 Dec 01;1348:1647-54. doi: 10.1038/sj.bjp.0704421.
Show Gene links
Show Anatomy links
A kinetic study on the stereospecific inhibition of KCNQ1 and I(Ks) by the chromanol 293B.
Seebohm G
,
Lerche C
,
Pusch M
,
Steinmeyer K
,
Brüggemann A
,
Busch AE
.
???displayArticle.abstract???
1. Recently we and others have demonstrated a stereoselective inhibition of slowly activating human I(Ks) (KCNQ1/MinK) and homomeric KCNQ1 potassium channels by the enantiomers of the chromanol 293B. Here, we further characterized the mechanism of the 293B block and studied the influence of the 293B enantiomers on the gating kinetics of both channels after their heterologous expression in Xenopus oocytes. 2. Kinetic analysis of currents partially blocked with 10 microM of each 293B enantiomer revealed that only 3R,4S-293B but not 3S,4R-293B exhibited a time-dependent block of I(Ks) and KCNQ1 currents, indicating preferential open channel block activity. 3. Inhibition of both KCNQ1 and I(Ks) channels by 3R,4S-293B but not by 3S,4R-293B increased during a 2 Hz train of stimuli. 4. At high extracellular potassium concentrations the inhibition of KCNQ1 by 3R,4S-293B and 3S,4R-293B was unaffected. Drug inhibition of KCNQ1 and I(Ks) by both enantiomers also did not display a significant voltage-dependence, indicating that 293B does not strongly interact with permeant ions in the pore. 5. The inhibitory properties of 3R,4S-293B on I(Ks)-channels but not those of 3S,4R-293B fulfill the theoretical requirements for a novel class III antiarrhythmic drug, i.e. positive use-dependency. This enantiomer therefore represents a valuable pharmacological tool to evaluate the therapeutic efficiency of I(Ks)blockade.
Armstrong,
Inactivation of the potassium conductance and related phenomena caused by quaternary ammonium ion injection in squid axons.
1969, Pubmed
Armstrong,
Inactivation of the potassium conductance and related phenomena caused by quaternary ammonium ion injection in squid axons.
1969,
Pubmed
Bara,
Regulation of sodium and potassium pathways by magnesium in cell membranes.
1993,
Pubmed
Barhanin,
K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current.
1996,
Pubmed
,
Xenbase
Bosch,
Effects of the chromanol 293B, a selective blocker of the slow, component of the delayed rectifier K+ current, on repolarization in human and guinea pig ventricular myocytes.
1998,
Pubmed
,
Xenbase
Busch,
The role of the IsK protein in the specific pharmacological properties of the IKs channel complex.
1997,
Pubmed
,
Xenbase
Fujisawa,
Time-dependent block of the slowly activating delayed rectifier K(+) current by chromanol 293B in guinea-pig ventricular cells.
2000,
Pubmed
Hondeghem,
Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence.
1990,
Pubmed
Lerche,
Molecular cloning and functional expression of KCNQ5, a potassium channel subunit that may contribute to neuronal M-current diversity.
2000,
Pubmed
,
Xenbase
Lerche,
Molecular impact of MinK on the enantiospecific block of I(Ks) by chromanols.
2000,
Pubmed
,
Xenbase
Loussouarn,
KvLQT1 potassium channel but not IsK is the molecular target for trans-6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethyl- chromane.
1997,
Pubmed
Pusch,
Activation and inactivation of homomeric KvLQT1 potassium channels.
1998,
Pubmed
,
Xenbase
Pusch,
Increase of the single-channel conductance of KvLQT1 potassium channels induced by the association with minK.
1998,
Pubmed
,
Xenbase
Roden,
Current status of class III antiarrhythmic drug therapy.
1993,
Pubmed
Salata,
A novel benzodiazepine that activates cardiac slow delayed rectifier K+ currents.
1998,
Pubmed
,
Xenbase
Sanguinetti,
Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes. Mechanism of action.
1991,
Pubmed
Sanguinetti,
Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel.
1996,
Pubmed
,
Xenbase
Sanguinetti,
Role of external Ca2+ and K+ in gating of cardiac delayed rectifier K+ currents.
1992,
Pubmed
Schreieck,
Differential effect of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of the new class III antiarrhythmics dofetilide, ambasilide, and chromanol 293B.
1997,
Pubmed
Seebohm,
Identification of specific pore residues mediating KCNQ1 inactivation. A novel mechanism for long QT syndrome.
2001,
Pubmed
,
Xenbase
Selnick,
Class III antiarrhythmic activity in vivo by selective blockade of the slowly activating cardiac delayed rectifier potassium current IKs by (R)-2-(2,4-trifluoromethyl)-N-[2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)- 2, 3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]acetamide.
1997,
Pubmed
,
Xenbase
Singh,
The coming of age of the class III antiarrhythmic principle: retrospective and future trends.
1996,
Pubmed
Suessbrich,
The IKs channel: coassembly of IsK (minK) and KvLQT1 proteins.
1999,
Pubmed
Suessbrich,
Specific blockade of slowly activating I(sK) channels by chromanols -- impact on the role of I(sK) channels in epithelia.
1996,
Pubmed
,
Xenbase
Takumi,
Cloning of a membrane protein that induces a slow voltage-gated potassium current.
1988,
Pubmed
,
Xenbase
Tristani-Firouzi,
Voltage-dependent inactivation of the human K+ channel KvLQT1 is eliminated by association with minimal K+ channel (minK) subunits.
1998,
Pubmed
,
Xenbase
Tzounopoulos,
Gating of I(sK) channels expressed in Xenopus oocytes.
1998,
Pubmed
,
Xenbase
Wang,
Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias.
1996,
Pubmed
Yang,
Stereoselective interactions of the enantiomers of chromanol 293B with human voltage-gated potassium channels.
2000,
Pubmed
